Income Statement Harmony Biosciences Holdings, Inc.

Equities

HRMY

US4131971040

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-15 pm EST			5-day change	1st Jan Change
36.93 ^USD	+1.40%		+6.95%	+7.32%

Jan. 15	Harmony Biosciences Holdings, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 11:15 AM
Jan. 13	Harmony Biosciences Reports Preliminary Q4, 2024 Net Product Revenue; 2025 Revenue Guidance Issued	MT

9b500944.h8CKDb0PwoW2aDmEpTDV_2YMZKAzT9tBRcmK412mX9g.zJqyWdddstDVAQrx8HH4lS41BcpYNpw7DJDilA7kMa_tqNVpjVDy38wDVg

Published financial data: HARMONY BIOSCIENCES HOLDINGS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	6M	160M	305M	438M	582M
Total Revenues	6M	160M	305M	438M	582M
Cost of Goods Sold, Total	1.58M	27.74M	55.52M	83.48M	121M
Gross Profit	4.42M	132M	250M	354M	461M
Selling General & Admin Expenses, Total	80.73M	95.57M	132M	163M	193M
R&D Expenses	69.6M	19.45M	30.37M	70.89M	76.06M
Other Operating Expenses, Total	150M	115M	162M	234M	269M
Operating Income	-146M	16.99M	87.53M	120M	192M
Interest Expense, Total	-6.07M	-28.22M	-23.97M	-18.8M	-23.76M
Interest And Investment Income	-	-	-	3.13M	14.73M
Net Interest Expenses	-6.07M	-28.22M	-23.97M	-15.67M	-9.03M
Other Non Operating Income (Expenses)	-	-3.07M	16K	169K	159K
EBT, Excl. Unusual Items	-152M	-14.3M	63.57M	105M	183M
Other Unusual Items	-	-22.64M	-26.15M	-	-9.77M
EBT, Incl. Unusual Items	-152M	-36.94M	37.43M	105M	173M
Income Tax Expense	-	-	2.83M	-76.78M	44.54M
Earnings From Continuing Operations	-152M	-36.94M	34.6M	181M	129M
Net Income to Company	-152M	-36.94M	34.6M	181M	129M
Net Income - (IS)	-152M	-36.94M	34.6M	181M	129M
Preferred Dividend and Other Adjustments	35.23M	26.9M	-	-	-
Net Income to Common Incl Extra Items	-187M	-63.85M	34.6M	181M	129M
Net Income to Common Excl. Extra Items	-187M	-63.85M	34.6M	181M	129M
Per Share Items
Net EPS - Basic	-24.07	-2.48	0.6	3.07	2.17
Basic EPS - Continuing Operations	-24.07	-2.48	0.6	3.07	2.17
Basic Weighted Average Shares Outstanding	7.78M	25.77M	57.53M	59.17M	59.47M
Net EPS - Diluted	-24.07	-2.48	0.58	2.97	2.13
Diluted EPS - Continuing Operations	-24.07	-2.48	0.58	2.97	2.13
Diluted Weighted Average Shares Outstanding	7.78M	25.77M	59.21M	61.1M	60.37M
Normalized Basic EPS	-12.21	-0.35	0.69	1.11	1.92
Normalized Diluted EPS	-12.21	-0.35	0.67	1.07	1.9
Supplemental Items
EBITDA	-143M	27.22M	106M	144M	216M
EBITA	-143M	26.83M	106M	143M	216M
EBIT	-146M	16.99M	87.53M	120M	192M
EBITDAR	-142M	27.91M	108M	145M	218M
Effective Tax Rate - (Ratio)	-	-	7.56	-73.34	25.69
Current Domestic Taxes	-	-	2.83M	9.16M	57.96M
Total Current Taxes	-	-	2.83M	9.16M	57.96M
Deferred Domestic Taxes	-	-	0	-85.94M	-13.42M
Total Deferred Taxes	-	-	0	-85.94M	-13.42M
Normalized Net Income	-94.99M	-8.94M	39.73M	65.43M	114M
Interest on Long-Term Debt	-	28.62M	24.19M	18.8M	23.76M
Supplemental Operating Expense Items
Advertising Expense	7.07M	13.3M	19.56M	22.43M	21.54M
Selling and Marketing Expenses	44.32M	55.82M	68.12M	79.28M	97.4M
General and Administrative Expenses	36.41M	39.75M	63.91M	84.02M	95.29M
Research And Development Expense From Footnotes	124M	31.29M	30.37M	70.89M	78.32M
Net Rental Expense, Total	1.05M	686K	1.2M	1.53M	1.81M
Imputed Operating Lease Interest Expense	-	1.06M	1.18M	1.18M	1.76M
Imputed Operating Lease Depreciation	-	-374K	15.24K	349K	47.38K
Stock-Based Comp., R&D Exp. (Total)	287K	586K	2.12M	2.61M	3.96M
Stock-Based Comp., S&M Exp. (Total)	351K	703K	3.1M	3.89M	5.15M
Stock-Based Comp., G&A Exp. (Total)	9.27M	3.9M	10.88M	20.4M	22.1M
Stock-Based Comp., Other (Total)	-	-	-	-	499K
Total Stock-Based Compensation	9.91M	5.19M	16.1M	26.9M	31.7M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	24.46M	229M	234M	244M	312M
Short Term Investments	-	-	-	79.33M	41.8M
Total Cash And Short Term Investments	24.46M	229M	234M	323M	353M
Accounts Receivable, Total	4.26M	22.18M	34.84M	54.74M	74.14M
Total Receivables	4.26M	22.18M	34.84M	54.74M	74.14M
Inventory	1.09M	3.82M	4.43M	4.3M	5.36M
Prepaid Expenses	1.44M	6.96M	7.64M	9.35M	12.57M
Other Current Assets, Total	261K	1.3M	3.22M	8.79M	5.54M
Total Current Assets	31.5M	263M	284M	400M	451M
Net Property Plant And Equipment	1.33M	938K	4.12M	2.88M	2.72M
Long-term Investments	-	-	-	22.57M	72.17M
Other Intangibles, Total	72.18M	162M	144M	161M	137M
Deferred Tax Assets Long-Term	-	-	-	85.94M	144M
Other Long-Term Assets, Total	1.69M	902K	967K	1.24M	4.22M
Total Assets	107M	427M	433M	674M	811M
Liabilities
Accounts Payable, Total	6.36M	2.56M	1M	3.79M	17.73M
Accrued Expenses, Total	12.78M	31.67M	49.41M	71.47M	123M
Current Portion of Long-Term Debt	-	-	2M	2M	15M
Current Portion of Leases	-	-	-	1.61M	1.44M
Other Current Liabilities	753K	100M	1.36M	10K	6.37M
Total Current Liabilities	19.89M	135M	53.78M	78.88M	164M
Long-Term Debt	97.95M	194M	190M	190M	179M
Long-Term Leases	-	-	2.23M	975K	1.08M
Other Non Current Liabilities	450K	1.1M	944K	1.53M	1.03M
Total Liabilities	118M	330M	247M	271M	344M
Preferred Stock Convertible	411M	-	-	-	-
Total Preferred Equity	411M	-	-	-	-
Common Stock, Total	1K	1K	1K	1K	1K
Additional Paid In Capital	-	585M	640M	675M	610M
Retained Earnings	-423M	-488M	-454M	-272M	-143M
Comprehensive Income and Other	-	-	-	-151K	2K
Total Common Equity	-423M	97.18M	187M	403M	467M
Total Equity	-11.58M	97.18M	187M	403M	467M
Total Liabilities And Equity	107M	427M	433M	674M	811M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	7.79M	56.89M	58.87M	59.62M	56.77M
ECS Total Common Shares Outstanding	7.79M	56.89M	58.83M	59.62M	56.77M
Book Value / Share	-54.3	1.71	3.17	6.76	8.23
Tangible Book Value	-495M	-65.16M	42.59M	242M	330M
Tangible Book Value Per Share	-63.57	-1.15	0.72	4.06	5.81
Total Debt	97.95M	194M	194M	194M	196M
Net Debt	73.49M	-34.38M	-40.09M	-129M	-157M
Debt Equivalent Oper. Leases	8.41M	5.49M	9.58M	12.21M	14.49M
Account Code - Inventory Valuation	5	5	5	8	8
Inventories - Raw Materials, Total	384K	396K	986K	838K	1.06M
Inventories - Work In Process, Total	417K	2.66M	1.79M	1.51M	2.02M
Inventories - Finished Goods, Total	287K	941K	2.11M	2.56M	2.28M
Full Time Employees	150	150	180	200	246

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-152M	-36.94M	34.6M	181M	129M
Depreciation & Amortization - CF	395K	394K	416K	419K	514K
Amortization of Goodwill and Intangible Assets - (CF)	2.82M	9.84M	18.42M	22.97M	23.84M
Depreciation & Amortization, Total	3.21M	10.24M	18.84M	23.38M	24.36M
Amortization of Deferred Charges, Total - (CF)	592K	2.41M	2.24M	1.66M	2.27M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-432K	-2.72M
Asset Writedown & Restructuring Costs	52M	2M	-	-	2.26M
Stock-Based Compensation (CF)	9.91M	4.69M	15.66M	26.17M	31.7M
Other Operating Activities, Total	2.54M	26.24M	26.59M	-83.68M	-2.38M
Change In Accounts Receivable	-4.26M	-17.92M	-12.67M	-19.9M	-19.4M
Change In Inventories	-1.09M	-2.74M	-609K	135K	-1.07M
Change In Accounts Payable	4.9M	-3.8M	-1.56M	2.78M	8.95M
Change in Other Net Operating Assets	8.74M	12.83M	15.46M	12.87M	46.55M
Cash from Operations	-75.44M	-2.98M	98.56M	144M	219M
Capital Expenditure	-149K	-2K	-298K	-172K	-312K
Cash Acquisitions	-	-	-	-	-36.97M
Sale (Purchase) of Intangible assets	-127M	-2M	-100M	-40M	-
Investment in Marketable and Equity Securities, Total	-	-	-	-102M	-9.16M
Cash from Investing	-127M	-2M	-100M	-142M	-46.44M
Long-Term Debt Issued, Total	100M	200M	200M	-	200M
Total Debt Issued	100M	200M	200M	-	200M
Long-Term Debt Repaid, Total	-	-103M	-200M	-2M	-201M
Total Debt Repaid	-	-103M	-200M	-2M	-201M
Issuance of Common Stock	85K	148M	39.37M	8.84M	5.06M
Repurchase of Common Stock	-	-184K	-	-	-101M
Issuance of Preferred Stock	50M	-	-	-	-
Other Financing Activities, Total	-6.32M	-36.04M	-31.45M	-	-8.84M
Cash from Financing	144M	209M	7.42M	6.84M	-106M
Net Change in Cash	-58.82M	204M	5.68M	9.48M	67.4M
Supplemental Items
Cash Interest Paid	4.23M	26.2M	19.83M	16.36M	20.05M
Cash Income Tax Paid (Refund)	-	-	2.88M	12.64M	48.23M
Levered Free Cash Flow	-200M	96.24M	-122M	72.97M	215M
Unlevered Free Cash Flow	-196M	111M	-109M	83.05M	227M
Change In Net Working Capital	-8.78M	-87.43M	98.63M	2.18M	-51.63M
Net Debt Issued / Repaid	100M	97.46M	-500K	-2M	-1.25M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-93.06	3.98	12.71	13.57	16.16
Return on Total Capital	-108.63	5.62	16.28	15.34	19.05
Return On Equity %	-434.57	-86.32	24.39	61.58	29.63
Return on Common Equity	56.26	39.21	24.39	61.58	29.63
Margin Analysis
Gross Profit Margin %	73.69	82.64	81.82	80.93	79.17
SG&A Margin	1.35K	59.83	43.23	37.3	33.11
EBITDA Margin %	-2.38K	17.04	34.82	32.79	37.18
EBITA Margin %	-2.39K	16.8	34.69	32.69	37.09
EBIT Margin %	-2.43K	10.63	28.66	27.45	32.99
Income From Continuing Operations Margin %	-2.54K	-23.13	11.33	41.44	22.14
Net Income Margin %	-2.54K	-23.13	11.33	41.44	22.14
Net Avail. For Common Margin %	-3.12K	-39.97	11.33	41.44	22.14
Normalized Net Income Margin	-1.58K	-5.6	13.01	14.94	19.67
Levered Free Cash Flow Margin	-3.33K	60.25	-39.95	16.66	36.91
Unlevered Free Cash Flow Margin	-3.28K	69.78	-35.78	18.97	39.07
Asset Turnover
Asset Turnover	0.06	0.6	0.71	0.79	0.78
Fixed Assets Turnover	4.13	140.87	120.82	125.05	207.86
Receivables Turnover (Average Receivables)	-	12.09	10.71	9.78	9.03
Inventory Turnover (Average Inventory)	-	11.3	13.45	19.13	25.1
Short Term Liquidity
Current Ratio	1.58	1.95	5.29	5.07	2.75
Quick Ratio	1.44	1.86	5.01	4.79	2.61
Operating Cash Flow to Current Liabilities	-3.79	-0.02	1.83	1.83	1.34
Days Sales Outstanding (Average Receivables)	-	30.28	34.07	37.34	40.41
Days Outstanding Inventory (Average Inventory)	-	32.4	27.14	19.08	14.54
Average Days Payable Outstanding	-	53.54	11.57	10.48	32.11
Cash Conversion Cycle (Average Days)	-	9.14	49.64	45.94	22.85
Long Term Solvency
Total Debt/Equity	-845.46	199.89	104.13	48.22	41.99
Total Debt / Total Capital	113.41	66.65	51.01	32.53	29.57
LT Debt/Equity	-845.46	199.89	103.06	47.32	38.47
Long-Term Debt / Total Capital	113.41	66.65	50.49	31.93	27.09
Total Liabilities / Total Assets	110.86	77.25	56.97	40.22	42.45
EBIT / Interest Expense	-24.03	0.6	3.65	6.39	8.08
EBITDA / Interest Expense	-23.5	0.96	4.49	7.72	9.18
(EBITDA - Capex) / Interest Expense	-23.52	0.96	4.48	7.71	9.17
Total Debt / EBITDA	-0.69	7.14	1.81	1.34	0.9
Net Debt / EBITDA	-0.52	-1.26	-0.37	-0.89	-0.72
Total Debt / (EBITDA - Capex)	-0.69	7.14	1.81	1.34	0.9
Net Debt / (EBITDA - Capex)	-0.51	-1.26	-0.37	-0.89	-0.72
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	2.56K	91.21	43.35	32.93
Gross Profit, 1 Yr. Growth %	-	2.89K	89.33	41.79	30.03
EBITDA, 1 Yr. Growth %	245.88	-119.55	290.73	34.98	50.72
EBITA, 1 Yr. Growth %	245.3	-119.22	294.92	35.11	50.8
EBIT, 1 Yr. Growth %	252.09	-111.93	415.29	37.31	59.78
Earnings From Cont. Operations, 1 Yr. Growth %	280.91	-75.69	-193.65	424.52	-28.99
Net Income, 1 Yr. Growth %	280.91	-75.69	-193.65	424.52	-28.99
Normalized Net Income, 1 Yr. Growth %	280.91	-90.37	-544.42	64.67	74.96
Diluted EPS Before Extra, 1 Yr. Growth %	204.22	-89.7	-123.39	412.07	-28.28
Accounts Receivable, 1 Yr. Growth %	-	421.18	57.12	57.1	35.44
Inventory, 1 Yr. Growth %	-	251.38	15.93	-3.05	24.81
Net Property, Plant and Equip., 1 Yr. Growth %	-15.61	-29.47	339.02	-29.94	-5.89
Total Assets, 1 Yr. Growth %	19.51	300.25	1.49	55.47	20.42
Tangible Book Value, 1 Yr. Growth %	104	-86.84	-165.36	467.97	36.38
Common Equity, 1 Yr. Growth %	74.25	-122.98	91.92	115.99	15.93
Cash From Operations, 1 Yr. Growth %	94.43	-96.04	-3.4K	46.58	51.86
Capital Expenditures, 1 Yr. Growth %	-88.9	-98.66	14.8K	-42.28	81.4
Levered Free Cash Flow, 1 Yr. Growth %	-	-148.74	-226.79	-159.07	194.43
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-157.38	-198.04	-175.06	173.82
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	613.79	65.56	38.04
Gross Profit, 2 Yr. CAGR %	-	-	652.12	63.85	35.78
EBITDA, 2 Yr. CAGR %	-	-18.77	-13.66	129.65	42.63
EBITA, 2 Yr. CAGR %	-	-19.54	-13.95	130.99	42.74
EBIT, 2 Yr. CAGR %	-	-35.98	-22.55	166	48.12
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-3.77	-52.29	121.63	92.99
Net Income, 2 Yr. CAGR %	-	-3.77	-52.29	121.63	92.99
Normalized Net Income, 2 Yr. CAGR %	-	-40.12	-35.32	170.52	69.74
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-44.01	-84.48	9.43	91.64
Accounts Receivable, 2 Yr. CAGR %	-	-	186.16	57.11	45.87
Inventory, 2 Yr. CAGR %	-	-	101.83	6.02	10
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-22.85	75.96	75.38	-18.8
Total Assets, 2 Yr. CAGR %	-	118.71	101.55	25.61	36.82
Tangible Book Value, 2 Yr. CAGR %	-	-48.18	-70.67	92.67	178.32
Common Equity, 2 Yr. CAGR %	-	-36.72	-33.59	103.6	58.24
Cash From Operations, 2 Yr. CAGR %	-	-72.26	14.3	595.68	49.2
Capital Expenditures, 2 Yr. CAGR %	-	-96.14	41.42	827.36	2.32
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-21.82	-12.82	31.88
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-25.41	-13.68	43.36
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	318	53.88
Gross Profit, 3 Yr. CAGR %	-	-	-	331.27	51.69
EBITDA, 3 Yr. CAGR %	-	-	37.12	0.2	99.57
EBITA, 3 Yr. CAGR %	-	-	36.74	0.01	100.39
EBIT, 3 Yr. CAGR %	-	-	28.31	-6.26	124.44
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-4.64	6.09	51.65
Net Income, 3 Yr. CAGR %	-	-	-4.64	6.09	51.65
Normalized Net Income, 3 Yr. CAGR %	-	-	16.8	-11.68	133.95
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-58.15	-50.22	-4.94
Accounts Receivable, 3 Yr. CAGR %	-	-	-	134.32	49.53
Inventory, 3 Yr. CAGR %	-	-	-	58.07	11.94
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	37.73	29.45	42.51
Total Assets, 3 Yr. CAGR %	-	-	69.33	84.84	23.86
Tangible Book Value, 3 Yr. CAGR %	-	-	-44.01	-21.24	71.71
Common Equity, 3 Yr. CAGR %	-	-	-8.4	-1.6